InMed Pharmaceuticals INM
NASDAQ INM
$1.36 +0.02 (+1.49%)
As of: Oct 21, 2026 · 11:12 AM EDT

InMed Pharmaceuticals (INM) Total Debt (2021 - 2022)

Updated

InMed Pharmaceuticals' Total Debt was $29,312 in fiscal Q3 2022 (quarter ended Mar 31, 2022), down 50.0% from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Total Debt (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Linde 231.69 Bn 213.27 Bn 4.43 Bn 28.01 Bn
2 Corning 116.83 Bn 109.39 Bn 1.63 Bn 8.47 Bn
3 Sherwin Williams 81.99 Bn 81.04 Bn 3.34 Bn 12.07 Bn
4 Air Products & Chemicals 67.46 Bn 62.65 Bn 1.04 Bn 17.48 Bn
5 LyondellBasell Industries 40.38 Bn 29.89 Bn 2.04 Bn 12.91 Bn
6 Nutrien 32.86 Bn 29.69 Bn 3.25 Bn 11.39 Bn
7 Qnity Electronics 25.31 Bn 22.45 Bn 666.00 Mn 4.02 Bn
8 Ati 24.99 Bn 23.01 Bn 309.80 Mn 2.19 Bn
9 Ppg Industries 24.45 Bn 17.10 Bn 1.81 Bn 6.89 Bn
10 InMed Pharmaceuticals 5.66 Mn 3.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 29,312.00
Dec 31, 2021 58,624.00
API Access

InMed Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=INM&period=max&api_key=YOUR_API_KEY